 |
Life Sciences and Biotechnology:
The Transatlantic Divide
|
Life sciences and biotechnology have seen
a rapid expansion over the last few years. Scientific advances
in genetics and molecular biology and their combination with
chemical engineering and new information technologies have
begun to transform the industrial landscape of the transatlantic
economy. These advances are having a lasting impact on a variety
of economic sectors, including healthcare, pharmaceuticals,
industrial processing and agro-production. Indeed, many analysts
are now talking about an emerging bio-economy that will be
of increasing global economic significance in the future.
This brief will focus on the different industrial profile
and political differences that characterize life sciences and
biotechnology in the United States and Europe. Are these differences
likely to lead to renewed regulatory and trade conflicts across
the Atlantic, or will the future yield to a more integrated
transatlantic “bio-economy”?
- Biotechnology in Europe and the United States
- Public Opinion and Regulatory Differences
- The Impact of the Financial Crisis
- Conclusion
|
